Real-world treatment patterns and outcomes associated with bevacizumab (bev) in metastatic colorectal cancer (mCRC).

被引:0
|
作者
Saverno, Kimberly
Walker, Mark S.
Hennessy, Daniel
Dhawan, Ravinder
机构
[1] Vector Oncol, Memphis, TN USA
[2] Sanofi US, Bridgewater, NJ USA
关键词
D O I
10.1200/jco.2015.33.15_suppl.e14553
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e14553
引用
收藏
页数:1
相关论文
共 50 条
  • [1] REAL-WORLD TREATMENT PATTERNS, SEQUENCING, AND UNMET NEED IN METASTATIC COLORECTAL CANCER (MCRC)
    Desai, K.
    Shao, C.
    Li, S.
    Hair, G. M.
    Liu, L.
    Jain, R.
    Amonkar, M.
    VALUE IN HEALTH, 2024, 27 (06) : S183 - S183
  • [2] Real-world treatment patterns and outcomes in refractory metastatic colorectal cancer
    Chiang, C. L.
    Choi, H. C.
    Lam, K. O.
    Chan, B. Y.
    Lee, S. F.
    Yeung, S. Y.
    Lau, K. S.
    Chan, S. Y.
    Choy, T. S.
    Yuen, K. K.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 5 - 13
  • [3] Impact of the addition of bevacizumab (Bev) to chemotherapy on survival in metastatic colorectal cancer (MCRC): A real-world population-based analysis.
    Kannappan, Sunand Nageswaran
    Arora, Rahul Krishan
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] Frequency and management of trifluridine/tipiracil (FTD/TPI) plus bevacizumab (BEV)-associated neutropenia in patients with refractory metastatic colorectal cancer (mCRC) in real-world practice
    Lago, N. Martinez
    Rendo, C. Reboredo
    Chucla, T. Calleja
    Salvador, M. Mateos
    Fernandez, F. Busto
    Gomez, J. de la Camara
    Reboredo-Lopez, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S100 - S101
  • [5] Bevacizumab Treatment for Metastatic Colorectal Cancer in Real-World Clinical Practice
    Dinu, Ioana Mihaela
    Mihaila, Mariana
    Diculescu, Mircea Mihai
    Croitoru, Vlad Mihai
    Turcu-Stiolica, Adina
    Bogdan, Diana
    Miron, Monica Ionela
    Lungulescu, Cristian Virgil
    Alexandrescu, Sorin Tiberiu
    Dumitrascu, Traian
    Buica, Florina
    Luca, Ioana Niculina
    Lungulescu, Cristina
    Negulescu, Madalina Cristina
    Gramaticu, Iulia Magdalena
    Cazacu, Irina Mihaela
    Croitoru, Adina Emilia
    MEDICINA-LITHUANIA, 2023, 59 (02):
  • [6] Treatment patterns and outcomes in metastatic colorectal cancer (mCRC).
    Cartwright, Thomas H.
    Wen, Lonnie Kent
    Harrell, Robyn K.
    Fox, Patricia S.
    Espirito, Janet L.
    Wang, Ed
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [7] Efficacy and safety of trifluridine/tipiracil and bevacizumab (FTD/TPI plus BEV) in patients with metastatic colorectal cancer (mCRC) in real-world practice.
    Lago, Nieves Martinez
    Reboredo, Margarita
    Gonzalez Gomez, Borja
    de Frutos Gonzalez, Belen
    Riesco Martinez, Maria Carmen
    Antonilli, Paula Carla
    Lopez Alfonso, Ana
    Gallardo Martin, Elena
    Fernandez Montes, Ana Fernandez
    Cabezon-Gutierrez, Luis
    Castineira, Antia Cousillas
    Ferreiro, Reyes
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 204 - 204
  • [8] Real-world effectiveness and safety of trifluridine-tipiracil (FTD/TPI) and bevacizumab (BEV) in refractory metastatic colorectal cancer (mCRC): The BeTAS trial.
    Lago, Nieves Martinez
    Gonzalez, Borja
    Martin, Elena Gallardo
    Montes, Ana Fernandez
    Castineira, Antia Cousillas
    Suarez, Begona Grana
    Maseda, Alberto Carral
    Augusto, Maria Luz Pellon
    Villarroel, Paula Gonzalez
    Gomez, Juan De La Camara
    Fernandez, Mercedes Salgado
    Lopez, Margarita Reboredo
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 51 - 51
  • [9] Impact of tumor site on bevacizumab (BEV) efficacy in metastatic colorectal cancer (mCRC)
    Wong, Hui-Li
    Field, Kathryn Maree
    Lomax, Anna
    Tacey, Mark
    Shapiro, Jeremy David
    McKendrick, Joseph James
    Zlmet, Allan Solomon
    Yip, Desmond
    Nott, Louise M.
    Jennens, Ross
    Richardson, Gary Edward
    Tie, Jeanne
    Kosmider, Suzanne
    Parente, Phillip
    Lim, Lionel
    Cooray, Prasad
    Tran, Ben
    Desai, Jayesh
    Wong, Rachel
    Gibbs, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] Age-related real-world outcomes for patients (pts) with metastatic colorectal cancer (mCRC).
    Curtis, Melissa
    Nussbaum, Nathan Coleman
    Hamrick, Harvey J.
    Bennette, Caroline Savage
    Meropol, Neal J.
    Miksad, Rebecca A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)